BIANCHI, GIOVANNA
 Distribuzione geografica
Continente #
EU - Europa 22.355
AS - Asia 2.210
NA - Nord America 1.669
SA - Sud America 189
Continente sconosciuto - Info sul continente non disponibili 181
AF - Africa 32
OC - Oceania 2
Totale 26.638
Nazione #
IT - Italia 21.958
US - Stati Uniti d'America 1.538
SG - Singapore 901
CN - Cina 544
VN - Vietnam 353
BD - Bangladesh 193
FR - Francia 189
BR - Brasile 108
HK - Hong Kong 78
FI - Finlandia 53
CA - Canada 46
DE - Germania 40
AR - Argentina 39
JP - Giappone 37
MX - Messico 28
CH - Svizzera 27
GB - Regno Unito 17
IN - India 15
JM - Giamaica 15
RU - Federazione Russa 14
IQ - Iraq 13
CO - Colombia 12
IE - Irlanda 10
NL - Olanda 10
CR - Costa Rica 9
ID - Indonesia 8
CL - Cile 7
HN - Honduras 7
PL - Polonia 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
VE - Venezuela 7
EC - Ecuador 6
JO - Giordania 6
MA - Marocco 6
TH - Thailandia 6
UY - Uruguay 6
ES - Italia 5
GT - Guatemala 5
PH - Filippine 5
TT - Trinidad e Tobago 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
AZ - Azerbaigian 3
DZ - Algeria 3
GR - Grecia 3
KZ - Kazakistan 3
PK - Pakistan 3
SE - Svezia 3
SV - El Salvador 3
TN - Tunisia 3
TR - Turchia 3
AT - Austria 2
AU - Australia 2
EG - Egitto 2
ET - Etiopia 2
IR - Iran 2
KW - Kuwait 2
KY - Cayman, isole 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UA - Ucraina 2
AG - Antigua e Barbuda 1
AL - Albania 1
BE - Belgio 1
BG - Bulgaria 1
BM - Bermuda 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
NO - Norvegia 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
Totale 26.454
Città #
Genova 13.268
Genoa 5.220
Rapallo 1.944
Vado Ligure 1.297
San Jose 406
Singapore 397
Lauterbourg 171
Ashburn 126
Ho Chi Minh City 113
Beijing 85
Hanoi 78
Hong Kong 74
New York 74
Santa Clara 54
Helsinki 52
Bordighera 38
Council Bluffs 38
Frankfurt am Main 37
Los Angeles 32
Milan 26
Tokyo 25
Zurich 24
Buffalo 22
Haiphong 19
Rome 18
Mexico City 17
Phoenix 17
São Paulo 15
Da Nang 14
Dallas 14
Naples 14
Atlanta 13
San Francisco 13
Chicago 12
Orem 12
Brooklyn 11
Houston 11
Montreal 10
Philadelphia 10
Palermo 9
Tianjin 9
Dublin 8
Biên Hòa 7
Buenos Aires 7
San José 7
Amsterdam 6
Baghdad 6
Charlotte 6
Guangzhou 6
Hải Dương 6
Leander 6
Turin 6
Valenza 6
London 5
Medellín 5
Newark 5
Seattle 5
Spokane 5
Tashkent 5
Toronto 5
Warsaw 5
Amman 4
Boardman 4
Cagliari 4
City of London 4
Denver 4
Detroit 4
Guatemala City 4
Hưng Yên 4
Iowa City 4
Kingston 4
Lansdowne 4
Las Vegas 4
Marseille 4
Miami 4
Minneapolis 4
Montevideo 4
Mumbai 4
Ninh Bình 4
Phủ Lý 4
Queens 4
Raleigh 4
Sacramento 4
San Antonio 4
Thái Nguyên 4
Verona 4
Washington 4
Albany 3
Alexandria 3
Asheville 3
Athens 3
Baku 3
Baltimore 3
Bologna 3
Brasília 3
Bắc Giang 3
Can Tho 3
Columbus 3
Da Lat 3
Garland 3
Totale 24.099
Nome #
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 349
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 299
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 260
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 246
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 233
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer 227
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 222
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. 221
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study 220
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 218
An upstream positive regulatory element in human GM-CSF promoter is recognized by NF-kB/Rel family members 207
Granulocyte-macrophage colony-stimulating factor activity in cerebrospinal fluid 206
Incidence of other neoplasia in Italian melanoma-prone families with p16 (GLy93Trp) mutation 201
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL 200
H and L ferritin gene expression in U937 cells induced to macrophagedifferentiation 198
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. 197
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma 194
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 192
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation 190
Cell-type–specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes 190
c-Rel and p65 subunits bind to an upstream NF-kB site in human granulocyte macrophage-colony stimulating factor promoter involved in phorbol ester response in 5637 cells 189
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families. 188
Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt 188
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL) 188
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 187
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLDmutation in Brenner tumor 186
Increased Risk of Colorectal Adenomas in Italian Subjects Carrying the p53 PIN3 A2-Pro72 Haplotype. 185
A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds 185
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone-families 181
Gly101Trp germline mutation in the CDKN2A gene in familial and non familial Ligurian melanoma patients 180
ANALISI GENOME-WIDE PER LA SUSCETTIBILITÀ AL MELANOMA: NUOVI LOCICHE CONFERMANO IL RUOLO DEI GENI DELLA PIGMENTAZIONE 180
Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens 179
A variant in FTO shows association with melanoma risk not due to BMI. 179
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents 176
Familial Melanoma and Pancreatic Cancer 173
A case of chronic myelogenous leukemia with unusual chromosomal abnormality. 171
Molecular characterization of an Italian series of sporadic GISTs. 170
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma 165
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 165
Clinical genetic testing for familial melanoma in Italy: a cooperative study. 164
An upstream negative regulatory element in human granulocyte-macrophage colony-stimulating factor promoter is recognised by AP1 family members 163
Genome-wide association study identifies three new melanoma susceptibility loci 163
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 160
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome 159
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 157
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. 157
Genetic testing for melanoma 156
Nevoid Basal Cell Carcinoma Syndrome in infants: improving diagnosis. 156
"Gestione Melanoma" un "database" relazionale per lo studio e l’approfondimento della relazione genotipo/fenotipo e genotipo/ambiente nel melanoma familiare e sporadico 155
Varianti polimorfiche del gene MC1R (Melanocortin receptor 1) nella popolazione ligure ed associazione con il rischio di melanoma 155
Intercellular adhesion molecule-1 (ICAM-1) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesions. 155
Analysis of p16 protein expression in familial melanoma patients: correlation with germline status. 154
High prevalence of the G101W germline mutation in the CDKN2A (P16INK4A) gene in 62 Italian malignant melanoma families 154
Electrophoretic pattern of NADPH - dependent oxidoreductive activities in the K562 and HL60 leukemic cell lines 153
Characterization of a triplex DNA-binding protein encoded by an alternative reading frame of loricrin 152
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3 152
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma 152
Identification of a SUFU germline mutation in a family with Gorlin syndrome 150
Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study. 150
High prevalence of the Gly101Trp germline mutation in the CDKN2A gene in 62 small Italian families 149
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma 148
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. 148
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 147
Coexisting NRAS and BRAF Mutations in Primary Familial Melanomas with Specific CDKN2A Germline Alterations. 147
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 146
Effect of primaquine on erythrocytes with NADH-methaemoglobin reductase deficiency and low glutathione reductase activity. 146
Italian Melanoma-prone Families:Germline mutational analysis and Clinical-Epidemiological Characterization 146
Lactoferrin as a possible transcriptional regulator 146
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma 145
Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. 145
Hereditary trichilemmal cysts: A proposal for the assessment of diagnostic clinical criteria 145
Linkage Analysis in melanoma prone families 144
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study 144
Urinary granulopoietic activity in chronic myelogenous leukemia: follow-up and correlation with various phases of the disease. 144
On the Xq13 breakpoint: clinical and cytogenetic observations in a patient with acute myelogenous leukemia. 144
A nuclear factor that Down-Modulates the Granulocyte-Macrophage Colony-Stimulating Factor Expression. 144
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding 144
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma from Liguria 144
What is new in melanoma research: genetics and epidemiology of melanoma in 2003? Review of a workshop held in Milan in May 2003 143
Patched homolog 1 gene mutation (p.G1093R) induces nevoid basal cell carcinoma syndrome and non-syndromic keratocystic odontogenic tumors: A case report. 143
Absence of melanocortin 1 receptor variants in Ligurian G101W families 143
Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas 143
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 142
Characterization of Ligurian Melanoma families and risk of occurence of other neoplasia 142
Expression and genomic configuration of GM-CSF, IL-3, M-CSFreceptor (C-FMS), early growth response gene-1 (EGR-1) and M-CSF genes in primary myelodysplastic syndromes 141
The role of AIRE polymorphisms in melanoma. 141
Mutation screening of the CDKN2A promoter melanoma families 140
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways 139
Unusual Ph translocations in CML: four new cases 138
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations 138
Analisi molecolare del gene PTCH nella Sindrome di Gorlin (Carcinoma Nevo Basocellulare NBCCS) 136
MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma 136
Inverse correlation between p16INK4A expression and NF-kappaB activation in melanoma progression 136
Novel MC1R variants in Ligurian melanoma patients and controls 135
Karyotype evolution in a case of chronic myelogenous leukemia with an unusual Philadelphia chromosome translocation, t(4;22), and an additional translocation, t(3;5). 135
Structure-activity relationships of novel substituted naphthalene diimides as anticancer agents 135
Analisi del gene della p16ink4 in pazienti con melanoma familiare e sporadico 134
Ink4/ARF germline mutations and additional neoplasia in pancretic cancer patients and their families 134
CDKN2A Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment 134
Masked Philadelphia chromosome caused by translocation (9;11;22) 134
Totale 16.810
Categoria #
all - tutte 82.891
article - articoli 62.630
book - libri 0
conference - conferenze 18.316
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.945
Totale 165.782


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.199 46 191 149 296 103 129 158 526 71 204 76 250
2022/20232.387 273 152 16 215 478 420 14 139 372 15 249 44
2023/20241.163 60 147 16 120 87 221 69 59 95 27 60 202
2024/20253.575 130 262 130 248 363 386 436 632 185 123 276 404
2025/20265.542 686 130 245 503 697 602 927 215 373 504 360 300
2026/2027530 530 0 0 0 0 0 0 0 0 0 0 0
Totale 26.638